These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21567193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diverticular disease: what is the best long-term treatment?
    Tursi A.
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):77-8. PubMed ID: 20134488
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
    Cuomo R, Cargiolli M, Andreozzi P, Zito FP, Sarnelli G.
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
    [Abstract] [Full Text] [Related]

  • 6. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G, Barbara G, Bosetti C, Cuomo R, Annibale B.
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [Abstract] [Full Text] [Related]

  • 7. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A.
    Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
    [Abstract] [Full Text] [Related]

  • 8. Review article: the current and evolving treatment of colonic diverticular disease.
    Tursi A, Papagrigoriadis S.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):532-46. PubMed ID: 19549266
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A, Papa A, Danese S.
    Aliment Pharmacol Ther; 2015 Sep 15; 42(6):664-84. PubMed ID: 26202723
    [Abstract] [Full Text] [Related]

  • 15. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
    Brandimarte G, Tursi A.
    Med Sci Monit; 2004 May 15; 10(5):PI70-3. PubMed ID: 15114281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.
    Raskin JB, Kamm MA, Jamal MM, Márquez J, Melzer E, Schoen RE, Szalóki T, Barrett K, Streck P.
    Gastroenterology; 2014 Oct 15; 147(4):793-802. PubMed ID: 25038431
    [Abstract] [Full Text] [Related]

  • 19. [Modern indications on the medical treatment of symptomatic diverticular disease].
    Ierfone N, Di Fulvio A, Pontone S, Terzakis P, Martino G, Pontone P.
    G Chir; 2006 Mar 15; 27(3):93-6. PubMed ID: 16681868
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.